Click here to view which Articles have been shared most in the last 6 months! Molecular Cancer Pancreatic cancer (PaCa) is an insidious and highly metastatic malignancy, with a 5-year survival rate of less than 5%. Heat shock transcription factor1 (HSF1) was overexpressed to promote glutaminolysis and activate mTOR in colorectal cancer (CRC). Impact Factor Calculations 2020 Molecular Biomedicine is a peer-reviewed, online open access, multidisciplinary journal that publishes the pioneer works of biomedicine, emphasizing on pathogenic mechanism and innovative techniques for diagnosis and therapy. Molecular Cancer Molecular Cancer Super-enhancers (SEs) play a crucial role in cancer, which is often associate with activated oncogenes. Journal Impact Factor List 2019. 19:127, This article has been retracted. Cancer Research: 9.727 Clinical Cancer Research: 10.107 Molecular Cancer Research: 4.630 Molecular Cancer Therapeutics: 5.615 * Blood Cancer Discovery, the latest AACR Journal, has not published long enough to have received an Impact Factor. Citation: Molecular Cancer 2020 19:100 Content type: Review.

Authors: Susan A. Kennedy, Maria E. Morrissey, Margaret R. Dunne, Fiona O’Connell, Clare T. Butler, Mary-Clare Cathcart, Amy M. Buckley, Brian J. Mehigan, John O. Larkin, Paul McCormick, Breandán N. Kennedy and Jacintha O’Sullivan, Authors: Yuichiro Takeda, Go Naka, Yoh Yamaguchi, Masao Hashimoto, Manabu Suzuki, Shinyu Izumi and Haruhito Sugiyama, Authors: Hakon Blomstrand, Henrik Green, Mats Fredrikson, Emma Gränsmark, Bergthor Björnsson and Nils O. Elander, Authors: Liqin Xia, Feng Li, Jun Qiu, Zhongming Feng, Zihan Xu, Zhengtang Chen and Jianguo Sun, Authors: Michael G. Culbertson, Kathleen Bennett, Catherine M. Kelly, Linda Sharp and Caitriona Cahir, Authors: William H Hall, Ramanathan Ramachandran, Samir Narayan, Ashesh B Jani and Srinivasan Vijayakumar, Authors: Qing Ji, Xuan Liu, Zhifen Han, Lihong Zhou, Hua Sui, Linlin Yan, Haili Jiang, Jianlin Ren, Jianfeng Cai and Qi Li, Authors: Eira S Roth, David T Fetzer, Bruce J Barron, Usha A Joseph, Isis W Gayed and David Q Wan, Authors: René Scheiden, Catherine Wagener, Ulrich Knolle, Walter Dippel and Catherine Capesius, Authors: Jan H. Beumer, Katherine Y. Fu, Bean N. Anyang, Jill M. Siegfried and Christopher J. Bakkenist. 19:99. Molecular Biomedicine is affiliated with Sichuan International Medical Exchange & Promotion Association (SCIMEA), sponsored by Chengdu BIOMEDICAL International Biomedicine Scientific Information Institute Company Limited , a registered company of which SCIMEA is the sole shareholder. Authors: Xiaoyu He, Peiwei Chai, Fang Li, Leilei Zhang, Chuandi Zhou, Xiaoling Yuan, Yongyun Li, Jie Yang, Yingxiu Luo, Shengfang Ge, He Zhang, Renbing Jia and Xianqun Fan, Citation: Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response. original article was published in Molecular Cancer Co-Editors-in-Chief:  Julio E. Celis and Kevin Ryan, Senior Associate Editors: J.E. Authors: Jiarong Chen, Aibin Liu, Zhihui Wang, Bin Wang, Xingxing Chai, Wenjie Lu, Ting Cao, Ronggang Li, Minyan Wu, Zhuming Lu, Wenguang Pang, Lin Xiao, Xiangmeng Chen, Yan Zheng, Qiong Chen, Jincheng Zeng…, Citation: 19:121. cancer, and how they should be connected to develop a coherent cancer research

and you may need to create a new Wiley Online Library account. If you have queries about presubmission enquiries,submission issues, peer review process, or the status of your manuscript, please contact the editorial office: editorial@molbiomed.org.

About the cover: In a patient with metastatic melanoma in which all tumors but one responded to PD-1 blockade, Gstalder and colleagues found that the tumor-suppressor gene FBXW7 had a loss-of-function mutation. 2020 19:129. 2019

19:125, The N6-methyladenosine (m6A), the most abundant modification in eukaryotic cells, regulates RNA transcription, processing, splicing, degradation, and translation. 2020 2020 The journal editorial office (editorial@molbiomed.org) is dedicated to providing professional and responsive service for authors.

19:124, The 2018 New collection: Advances in CAR-T immunotherapy, Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors, Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring, Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel, Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1, The psychosocial determinants of quality of life in breast cancer survivors: a scoping review, An electronic application for rapidly calculating Charlson comorbidity score, Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression, Does colon cancer ever metastasize to bone first?

Molecular Cancer 2018 19:145. Impact Factor. Authors: Chunxiao Li, Ping Jiang, Shuhua Wei, Xiaofei Xu and Junjie Wang, Citation: Enter your email address below and we will send you your username, If the address matches an existing account you will receive an email with instructions to retrieve your username, © 2020 Federation of European Biochemical Societies. 2020 Authors: Anquan Shang, Chenzheng Gu, Weiwei Wang, Xuan Wang, Junjun Sun, Bingjie Zeng, Chen Chen, Wenjing Chang, Yili Ping, Ping Ji, Junlu Wu, Wenqiang Quan, Yiwen Yao, Yongxin Zhou, Zujun Sun and Dong Li, Citation:

18:25. Triple negative breast cancer (TNBC) remains the most challenging breast cancer subtype so far. Authors: Zijian Zhou, Jiancheng Lv, Hao Yu, Jie Han, Xiao Yang, Dexiang Feng, Qikai Wu, Baorui Yuan, Qiang Lu and Haiwei Yang, Citation: © 2020 Springer Nature Switzerland AG. The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. Molecular Cancer It contains over 12000 Journals. Impact Factor List of All Journals - 2020 - This is a list of journal impact factor from all over the world with publisher. With a focus on cancer, first author, Prof Kelley, provides a practical, stepwise approach for systematically reviewing the literature and publishing the results. 19:102. 2020 By using this website, you agree to our Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. Impact Factor. Published on: 2 June 2020. The emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients. 2020 Authors: Shuo Ma, Shan Kong, Feng Wang and Shaoqing Ju, Citation: Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems. 2020 19:120. This thematic issue on Radiation Oncology discusses central questions of the future direction and development of radiotherapy in Europe. Molecular Biomedicine is a peer-reviewed, online open access, multidisciplinary journal that publishes the pioneer works of biomedicine, emphasizing on pathogenic mechanism and innovative techniques for diagnosis and therapy. Authors: Yongyan Wu, Yuliang Zhang, Xiwang Zheng, Fengsheng Dai, Yan Lu, Li Dai, Min Niu, Huina Guo, Wenqi Li, Xuting Xue, Yunfeng Bo, Yujia Guo, Jiangbo Qin, Yixiao Qin, Hongliang Liu, Yu Zhang…, Citation: Inactivation of the tumor suppressor p53 is critical for pathogenesis of glioma, in particular glioblastoma multiforme (GBM). Biomarkers: diagnosis, prognosis, stratification and efficacy. 19:146. Due to the DNA repair defect, BRCA1/2 deficient tumor cells are more sensitive to PARP inhibitors (PARPi) through the mechanism of synthetic lethality.

19:103. 2020

Authors: Wenjing Wang, Mengyue Zhao, Lijuan Cui, Yong Ren, Jingyuan Zhang, Junli Chen, Lina Jia, Jiayu Zhang, Jingyu Yang, Guoliang Chen, Charles R. Ashby Jr, Chunfu Wu, Zhe-Sheng Chen and Lihui Wang, Citation: Molecular Cancer Molecular Cancer 2020 19:126, The An amendment to this paper has been published and can be accessed via the original article. Molecular Pain (MPX) is a peer-reviewed open access journal which focuses on providing a forum for molecular pain scientists to communicate their research findings in a targeted manner to others in this important and growing field. 19:128. 2020 Towards a cancer mission in Horizon Europe: recommendations. Deregulated circular RNAs (circRNAs) are associated with the development of cancer and therapy resistance. 2020 Chimeric antigen receptor (CAR) T cells therapies, as a novel modality in cancer immunotherapy, provide a quantum leap in the treatment of cancer. 2020 The journal covers topics including but not limited to genetics/epigenetics, molecular biology, cell biology, bioinformatics, pharmacology, pharmacy, and clinical medicine. Authors: Sailan Zou, Qiyu Tong, Bowen Liu, Wei Huang, Yan Tian and Xianghui Fu, Citation:

Natural killer (NK) cells play a critical role in the innate antitumor immune response. The development of resistance to gemcitabine is still a major challenge. Authors: Yaqing Li, Zhenfeng Tian, Ying Tan, Guoda Lian, Shangxiang Chen, Shaojie Chen, Jiajia Li, Xuanna Li, Kaihong Huang and Yinting Chen, Citation: Addressing the issue of preventing hearing loss and tinnitus through recreational noise exposure, Sign up for article alerts and news from this journal. - 46.22.212.251. Cancer Discovery's latest Impact Factor: 29.497 Read the September issue! original article was published in Molecular Cancer 2019